RaQualia Pharma Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	3,979	3,107	1,901	2,918	2,776
Revenue Growth (YoY)	28.07%	63.44%	-34.85%	5.12%	150.77%
Cost of Revenue	712	625	245	231	321
Gross Profit	3,267	2,482	1,656	2,687	2,455
Selling, General & Admin	893	782	615	566	615
Research & Development	1,599	1,703	1,372	1,248	1,127
Amortization of Goodwill & Intangibles	285	203	-	-	-
Operating Expenses	2,784	2,695	1,993	1,820	1,747
Operating Income	483	-213	-337	867	708
Interest Expense	-59	-42	-7	-6	-1
Interest & Investment Income	26	8	9	13	22
Currency Exchange Gain (Loss)	-40	38	52	43	145
Other Non Operating Income (Expenses)	1	-130	11	-17	-1
EBT Excluding Unusual Items	411	-339	-272	900	873
Gain (Loss) on Sale of Investments	-	4	-	-35	16
Asset Writedown	26	-23	-22	3	-10
Other Unusual Items	-	-	-	-18	-
Pretax Income	437	-358	-294	850	879
Income Tax Expense	164	137	29	127	124
Net Income	273	-495	-323	723	755
Net Income to Common	273	-495	-323	723	755
Net Income Growth	-	-	-	-4.24%	-
Shares Outstanding (Basic)	24	22	22	21	21
Shares Outstanding (Diluted)	24	22	22	21	21
Shares Change (YoY)	11.14%	0.16%	2.97%	0.05%	0.10%
EPS (Basic)	11.52	-22.87	-14.95	34.48	36.03
EPS (Diluted)	11.36	-22.87	-14.95	34.47	36.03
EPS Growth	-	-	-	-4.34%	-
Free Cash Flow	-421	84	-923	1,449	274
Free Cash Flow Per Share	-17.50	3.88	-42.72	69.06	13.06
Gross Margin	82.11%	79.88%	87.11%	92.08%	88.44%
Operating Margin	12.14%	-6.86%	-17.73%	29.71%	25.50%
Profit Margin	6.86%	-15.93%	-16.99%	24.78%	27.20%
Free Cash Flow Margin	-10.58%	2.70%	-48.55%	49.66%	9.87%
EBITDA	970	188	-162	1,014	849
EBITDA Margin	24.38%	6.05%	-8.52%	34.75%	30.58%
D&A For EBITDA	487	401	175	147	141
EBIT	483	-213	-337	867	708
EBIT Margin	12.14%	-6.86%	-17.73%	29.71%	25.50%
Effective Tax Rate	37.53%	-	-	14.94%	14.11%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.